Clinical Trial Update: Liposomal Bupivacaine in Vaginal Hysterectomy [Phase 4]

View source ↗

Summary

Phase 4 trial update on liposomal bupivacaine for pain management in vaginal hysterectomy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Hysterectomy Pain Management

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Mayo Clinic | Conditions: Vaginal Hysterectomy | Phase 4 | Status: TERMINATED | Results posted: 2021-10-15